Mandate

Vinge advises Nordic Re-Finance AB on a Swedish railway financing

January 21, 2026 M&A Banking and Finance

Vinge has acted as Swedish legal counsel to Nordic Re-Finance AB, a leading lessor of locomotives for rail freight traffic in Scandinavia, in connection with the execution of a EUR 250m debt package fully underwritten by Natixis CIB.

The facilities agreement enables the refinancing of the company's existing debt, supports its continued growth strategy and includes a green facility that will enable the acceleration of the company's electrification plans and expansion into new European markets.
 
Nordic Re-Finance AB is backed by Infranity, a French asset management company specializing in sustainable infrastructure investments.
 
Vinge's team consisted mainly of Helena Göransson, Calle Tengwall Pagels and Rebecka Margolin (Banking and Finance) as well as Matthias Pannier, Sara Hammond (M&A) and Victor Ericsson (Tax).

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026